Head-to-head · free
SAP vs Sabra Healthcare REIT
SAP vs SBRA — return on capital, cash generation, margins and balance sheet side by side.
SAP
4 / 5
measures where SAP leads
SBRA
1 / 5
measures where SBRA leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | SAP | SBRA · FY2025 |
|---|---|---|
| Revenue | — | $774.6M |
| Net income | — | $155.6M |
| Revenue growth (yearly, multi-year) | — | 8.0% |
| Free cash flow | — | — |
| Free cash flow margin | — | — |
| Net cash / (debt) | — | — |
| ROIC | 12.4% | 4.8% |
| Return on equity | 15.9% | 5.6% |
| Gross margin | 72.9% | 65.0% |
| Operating margin | 26.1% | 34.1% |
| Net debt / EBITDA | -0.22x | 5.55x |
Figures are as reported by each company; latest fiscal year shown.
Where Sabra Healthcare REIT's cash went (FY2025)
- Capital spending
- —
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free